Riggs Asset Managment Co. Inc. Makes New $12.99 Million Investment in SPDR S&P Biotech ETF $XBI

Riggs Asset Managment Co. Inc. acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 106,548 shares of the exchange traded fund’s stock, valued at approximately $12,991,000. SPDR S&P Biotech ETF makes up about 2.6% of Riggs Asset Managment Co. Inc.’s investment portfolio, making the stock its 9th largest position.

Several other large investors have also modified their holdings of the company. AQR Capital Management LLC raised its position in SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after purchasing an additional 2,167 shares during the last quarter. Marshall Wace LLP boosted its stake in SPDR S&P Biotech ETF by 102.3% during the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after purchasing an additional 179,029 shares during the period. The Manufacturers Life Insurance Company purchased a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $260,000. Ameriprise Financial Inc. grew its position in SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the last quarter. Finally, EP Wealth Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.7% in the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after purchasing an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $134.49 on Friday. The firm’s fifty day moving average is $127.28 and its two-hundred day moving average is $121.69. SPDR S&P Biotech ETF has a one year low of $75.68 and a one year high of $139.19. The firm has a market cap of $8.73 billion, a PE ratio of 11.47 and a beta of 0.88.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.